MedLumics is an ISO 13485 and ISO 9001 certified medical device company specializing in optically guided medical devices for the treatment of heart arrythmias. The AblaView Unipolar Pulsed Field (PF) Ablation System, in clinical trials development, features MedLumics unique, real-time, fiber optic, visually guided AF ablation technology. Its proprietary integrated optics platform technology combines optical and electrical components, enabling multi-view optically guided treatment with high-quality real-time images during cardiac ablation.
Peter Hinchliffe, CEO
Christophe Bailleul, VP clinical and regulatory affairs
Lucia Colmenero, Finance Director